A consensus document provides best practice guidelines for antithrombotic management in patients with atrial fibrillation presenting with acute coronary syndrome or undergoing coronary stenting.
What is the optimal antithrombotic management strategy for patients with atrial fibrillation presenting with acute coronary syndrome and/or undergoing coronary stenting?
This consensus document provides best practice recommendations for antithrombotic therapy in patients with atrial fibrillation who present with acute coronary syndrome or undergo coronary stenting.
There remains uncertainty over optimal antithrombotic management strategy for patients with atrial fibrillation (AF) presenting with an acute coronary syndrome and/or undergoing percutaneous coronary intervention/stenting. Clinicians need to balance the risk of stroke and thromboembolism against the risk of recurrent cardiac ischaemia and/or stent thrombosis and the risk of bleeding. The full consensus document comprehensively reviews the published evidence and presents a consensus statement on a 'best practice' antithrombotic therapy guideline for the management of antithrombotic therapy in such AF patients. This executive summary highlights the main recommendations from the consensus document.
Lip et al. (2010) conducted a review in Atrial fibrillation with acute coronary syndrome and/or coronary stenting. Antithrombotic management strategy was evaluated. A consensus document provides best practice guidelines for antithrombotic management in patients with atrial fibrillation presenting with acute coronary syndrome or undergoing coronary stenting.